Isotretinoin Capsule, Liquid Filled
Product Images NDC 68308-575

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Isotretinoin (NDC 68308-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Isotretinoin 01)

FDA Label Image

Figure 1 (Isotretinoin 02)

Figure 1 (Isotretinoin 02)
This is a report displaying mean lesion counts at different week intervals during a trial of isotretinoin capsules. The data is presented through a chart with values represented by symbols such as "o," "T," and "*" at different weeks starting from the baseline up to week 20.*
FDA Label Image

Principal Display Panel (40 mg Capsule Prescription Pack Carton)

Principal Display Panel (40 mg Capsule Prescription Pack Carton)
This is a description of a medication called Isotretinoin, which comes in capsule form containing 40mg of the drug. The medication guide is included and should be dispensed with the prescription only. There are special instructions for pharmacists, including dispensing the medication to registered patients only, and not to dispense it for more than 30 days. The medication is contraindicated in pregnancy and can cause birth defects. It should be stored at 20°-25°C and protected from light. The medication is distributed by Mayne Pharma and is a product of Germany, manufactured in New Zealand.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.